Compare SEZL & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SEZL | TWST |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.2B |
| IPO Year | 2023 | 2018 |
| Metric | SEZL | TWST |
|---|---|---|
| Price | $129.20 | $119.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $109.33 | $46.88 |
| AVG Volume (30 Days) | 769.1K | ★ 1.5M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ 2.64 | N/A |
| Revenue | ★ $450,279,000.00 | $376,572,000.00 |
| Revenue This Year | $30.30 | $18.91 |
| Revenue Next Year | $24.79 | $15.07 |
| P/E Ratio | $49.17 | ★ N/A |
| Revenue Growth | ★ 66.08 | 20.32 |
| 52 Week Low | $49.50 | $23.30 |
| 52 Week High | $195.71 | $126.40 |
| Indicator | SEZL | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 40.81 | 63.95 |
| Support Level | $59.42 | $84.39 |
| Resistance Level | $188.31 | N/A |
| Average True Range (ATR) | 10.61 | 7.99 |
| MACD | -4.41 | 2.19 |
| Stochastic Oscillator | 23.07 | 84.60 |
Sezzle Inc is a financing institution that offers technology-driven payment platform. The Sezzle Platform offers a payments solution for consumers in the United States and Canada that has the ability to instantly extend credit at the point-of-sale, allowing consumers to purchase and receive merchandise while paying in installments over time. Consumers pay a portion of the purchase price at the point-of-sale as a down payment, and then pay off the remaining amount over time through scheduled payments. It also offer the ability to pay-in-full using the Sezzle Platform. Its operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.